Best Practice & Research Clinical Rheumatology
Volume 21, Issue 2 , Pages 223-244 , April 2007

Neuropathic pain in soft tissue complaints

  • Mark J. Abrahams, FRCA (Consultant in Pain Management)

      Affiliations

    • Corresponding Author InformationTel.: +1 223 217796; Fax: +1 223 257063.

References 

  1. Finnerup NB, Jensen TS. Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis. Nature Clinical Practice. Neurology. 2006;2(2):107–115
  2. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology. 1997;48(2):332–338
  3. Bennett MI, Smith BH, Torrance N, Potter J. The s-lanss score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. Journal of Pain. 2005;6(3):149–158
  4. Cairns BE, Svensson P, Wang K, et al. Activation of peripheral nmda receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. Journal of Neurophysiology. 2003;90(4):2098–2105
  5. Woolf CJ, Bennett GJ, Doherty M, et al. Towards a mechanism-based classification of pain?. Pain. 1998;77(3):227–229
  6. Kim H, Neubert JK, San MA, et al. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain. 2004;109(3):488–496
  7. Diatchenko L, Anderson AD, Slade GD, et al. Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 2006;141(5):449–462
  8. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–1625
  9. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery: a review of predictive factors. Anesthesiology. 2000;93(4):1123–1133
  10. North RA. P2×3 receptors and peripheral pain mechanisms. Journal of Physiology. 2004;554(Pt 2):301–308
  11. Lai J, Gold MS, Kim CS, et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, nav18. Pain. 2002;95(1–2):143–152
  12. Gold MS, Weinreich D, Kim CS, et al. Redistribution of nav18 in uninjured axons enables neuropathic pain. Journal of Neuroscience. 2003;23(1):158–166
  13. Blackburn MG, Jensen BS. The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. European Journal of Pharmacology. 2003;460(2-3):109–116
  14. Simpson D. Gabapentin and venlafaxine for the treatment of diabetic neuropathy. Journal of Clinical Neuromuscular Disease. 2001;3(2):53–62
  15. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine. 2005;352(13):1324–1334
  16. Hempenstall K, Nurmikko TJ, Johnson RW, et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Medicine. 2005;2(7):1549–1676
  17. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118(3):289–305
  18. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs placebo in patients with painful diabetic neuropathy. Pain. 2005;116(1-2):109–118
  19. Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Medicine. 2005;6(5):346–356
  20. Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119(1-3):5–15
  21. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis and Rheumatism. 2004;50(9):2974–2984
  22. Sindrup SH, Bach FW, Madsen C, et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology. 2003;60(8):1284–1289
  23. Forssell H, Tasmuth T, Tenovuo O, et al. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. Journal of Orofacial Pain. 2004;18(2):131–137
  24. Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion sr for the treatment of neuropathic pain. Neurology. 2001;57(9):1583–1588
  25. Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. Journal of Pain. 2005;6(4):253–260
  26. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005;115(3):254–263
  27. Dogra S, Beydoun S, Mazzola J, et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. European Journal of Pain. 2005;9(5):543–554
  28. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology. 2001;57(3):505–509
  29. Vestergaard K, Andersen G, Gottrup H, et al. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56(2):184–190
  30. Finnerup NB, Sindrup SH, Bach FW, et al. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain. 2002;96(3):375–383
  31. Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology. 2003;60(9):1508–1514
  32. McCleane G. 200mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial. Pain. 1999;83(1):105–107
  33. Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 2004;63(5):865–873
  34. Thienel U, Neto W, Schwabe SK, et al. Topiramate in painful diabetic polyneuropathy: Findings from three double-blind placebo-controlled trials. Acta Neurologica Scandinavica. 2004;110(4):221–231
  35. In:  Collins A,  Simpson K editor. Recommendations for the appropriate use of opioids for persistent non-cancer pain. A consensus statement prepared on behalf of the Pain Society, The Royal College of Anaesthetists, The Royal College of General Practitioners and the Royal College of Psychiatrists. London: The Pain Society; March 2004;Available at: http://www.britishpainsociety.org/opioids_doc_2004.pdfMarch 2004;
  36. Kalso E, Allan L, Dellemijn PLI, et al. Recommendations for using opioids in chronic non-cancer pain. European Journal of Pain. 2003;7(5):381–386
  37. Breivik H. Opioids in chronic non-cancer pain, indications and controversies. European Journal of Pain. 2005;9(2):127–130
  38. Furlan AD, Sandoval JA, Mailis GA, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Canadian Medical Association Journal. 2006;174(11):1589–1594
  39. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50(6):1842–1846
  40. Sindrup SH, Andersen G, Madsen C, et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain. 1999;83(1):85–90
  41. Boureau F, Legallicier P, Kabir AM. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain. 2003;104(1-2):323–331
  42. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59(7):1015–1021
  43. Harke H, Gretenkort P, Ladleif HU, et al. The response of neuropathic pain and pain in complex regional pain syndrome to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesthesia and Analgesia. 2001;92(2):488–495
  44. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50(6):1837–1841
  45. Watson CPN, Moulin D, Watt WJ, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105(1-2):71–78
  46. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60(6):927–934
  47. Sorge J, Sittl R. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clinical Theraputics. 2004;26(11):1808–1820
  48. Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clinical Theraputics. 2003;25(1):150–168
  49. Morley JS, Bridson J, Nash TP, et al. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliative Medicine. 2003;17(7):576–587
  50. Manfredi PL. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003;60(6):1052–1053
  51. Eisenach JC, Hood DD, Curry R. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers. Anesthesia and Analgesia. 1998;87(3):591–596
  52. Semenchuk MR, Sherman S. Effectiveness of tizanidine in neuropathic pain: an open-label study. Journal of Pain. 2000;1(4):285–292
  53. Fromm GH. Baclofen as an adjuvant analgesic. Journal of Pain and Symptom Management. 1994;9(8):500–509
  54. Galer BS, Jensen MP, Ma T, et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clinical Journal of Pain. 2002;18(5):297–301
  55. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;80(3):533–538
  56. Kannan TR, Saxena A, Bhatnagar S, Barry A. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. Journal of Pain and Symptom Management. 2002;23(1):60–65
  57. Sang CN, Booher S, Gilron I, et al. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology. 2002;96(5):1053–1061
  58. Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65(6):812–819
  59. Chen H, Lamer TJ, Rho RH, et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clinic Proceedings. 2004;79(12):1533–1545
  60. Pincus T, Vlaeyen JWS, Kendall NAS, et al. Cognitive–behavioral therapy and psychosocial factors in low back pain: directions for the future. Spine. 2002;27(5):E109–E120

PII: S1521-6942(06)00148-3

doi: 10.1016/j.berh.2006.12.005

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 2 , Pages 223-244 , April 2007

Article Tools

* Image Usage & Resolution